Roby Reuven Zomer, Co-Founder & Chief Executive Officer at Argent Biopharma, holds 33.82M shares in Argent Biopharma (Ticker: RGTLF), holds 17.44M shares in Graft Polymer (UK) PLC (Ticker: GB:GPL). Most recently, Roby Reuven Zomer ― shares of Argent Biopharma on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Roby Reuven Zomer?
The percentage of profitable transactions made by Roby Reuven Zomer is 0%.
What is the average return per transaction made by Roby Reuven Zomer?
The average return per transaction made by Roby Reuven Zomer is -71.50%.
What stocks does Roby Reuven Zomer hold?
Roby Reuven Zomer holds: RGTLF, GB:GPL stocks.
What was Roby Reuven Zomer’s latest transaction?
Roby Reuven Zomer latest transaction was an Uninformative Buy of ―.
What was Roby Reuven Zomer's most profitable transaction?
Roby Reuven Zomer’s most profitable transaction was an Informative Buy of GB:GPL stock on January 8, 2024. The return on the trade was -69.20%.
What is Roby Reuven Zomer's role in Argent Biopharma?
Roby Reuven Zomer's role in Argent Biopharma is Co-Founder & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.